Premium
Defining small vessels and bioresorbable vascular scaffold outcomes
Author(s) -
Velagapudi Poonam,
Abbott J. Dawn
Publication year - 2016
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.26707
Subject(s) - medicine , bioresorbable scaffold , thrombosis , scaffold , radiology , surgery , percutaneous coronary intervention , biomedical engineering , myocardial infarction
Key Points Bioresorbable vascular scaffolds (BVS) are non‐inferior to second generation drug eluting stents (DES) but thrombosis rates for BVS in small vesseles is a concern. The BVS‐SAVE registry of small vesseles (<2.75 mm) supports safety and efficacy of BVS in this high risk lesion subset. Definitive recommendation for BVS in small vessels require further trials DES with evaluation of the lower threshold for minimal reference vesseles diameter.